Search results
Acadia (ACAD) Expands Existing Licensing Deal With Neuren
Zacks via Yahoo News· 1 year agoAcadia (ACAD) rises 23% for extending its existing licensing agreement with Neuren to include...
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
Zacks via Yahoo News· 7 months agoAnavex (AVXL) falls 35% on mixed results from the mid to late-stage study of 30 mg ANAVEX2-73 for...
Acadia's (ACAD) Nuplazid Sales Drive Growth Amid Competition
Zacks via Yahoo News· 7 months agoAcadia (ACAD) is witnessing robust growth in revenues, driven by Nuplazid and Daybue sales. However,...
Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs
Zacks via Yahoo News· 4 months agoQuest Diagnostics (DGX) collaboration is intended to demonstrate the clinical value of WGS as a...
Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up
Zacks via Yahoo News· 9 months agoAcadia (ACAD) reports better-than-expected third-quarter 2023 results as both earnings and sales...
London's most jaw-dropping Christmas homes and streets to visit this year
Evening Standard via Yahoo News· 8 months agoFrom programming 69,000 lightbulbs individually to a Christmas tradition spanning 40 years, we spoke...
Acadia (ACAD) Soars 24.7%: Is Further Upside Left in the Stock?
Zacks via Yahoo News· 1 year agoAcadia (ACAD) saw its shares surge in the last session with trading volume being higher than...
Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAA
Zacks via Yahoo News· 7 months agoThe CHMP agrees that Anavex's (AVXL) blarcamesine for Alzheimer's disease is eligible for submission...